INNOVATE Corp.: MediBeacon receives regulatory approval to sell the Transdermal GFR System in China

MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal functionThe TGFR will be available for sa ...
Rheumatology Advisor

Albuminuria Linked With Increased Cancer Risks

Investigators assessed markers of chronic kidney disease (CKD) with cancer risks using data from more than one million patients.

MediBeacon receives regulatory approval to sell the Transdermal GFR System in China

MediBeacon® Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in ...